# Sarentis Therapeutics Inc: Form D filings

Sarentis Therapeutics Inc, a pharmaceuticals company in New York, NY, filed 2 Form D notices with the SEC between 2009 and 2015. The latest, on July 8, 2015, reports $750,000 sold of a $1 million offering to 1 investor.

Find out what Sarentis Therapeutics Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Sarentis%20Therapeutics%20Inc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Sarentis%20Therapeutics%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fsarentis-therapeutics-inc-1477584)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Sarentis%20Therapeutics%20Inc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Sarentis%20Therapeutics%20Inc&page=%2Fdata%2Fform-d%2Fcompany%2Fsarentis-therapeutics-inc-1477584)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New York](https://specstream.ai/data/form-d/state/new-york): 4,357 rows, by operating companies, filed since November 1, 2024, $123.57, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-york
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 70 E 77TH ST APT 9C, New York, NY, 10021
- Phone: (212) 861-6348
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: No Revenues
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1477584

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 8, 2015 | New notice | $1,000,000 | $750,000 | $250,000 | 1 | Jun 24, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1477584/000147758415000001/0001477584-15-000001-index.htm) |
| Nov 25, 2009 | New notice | $3,609,654 | $3,609,654 | $0 | 5 | Nov 10, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1477584/000147758409000001/0001477584-09-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Denise Barbut | Executive Officer, Director, Promoter |  |

## Other pharmaceuticals companies in New York that filed recently

- [NBO Pharma Inc.](https://specstream.ai/data/form-d/company/nbo-pharma-inc-2103906) $238,000 · Nov 9, 2026
- [Pierrepont Therapeutics, Inc.](https://specstream.ai/data/form-d/company/pierrepont-therapeutics-inc-2019360) $2.4 million · Sep 22, 2026

[Every Form D from the week of Jul 6, 2015](https://specstream.ai/data/form-d/week/2015-07-06) · [All recent filings in New York](https://specstream.ai/data/form-d/state/new-york) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Sarentis Therapeutics Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).